Amneal Pharmaceuticals Inc Class A (NYSE:AMRX) Shorted Shares Increased By 8.4%

October 2, 2018 - By Ruchi Gupta

The stock of Amneal Pharmaceuticals Inc Class A (NYSE:AMRX) registered an increase of 8.4% in short interest. AMRX’s total short interest was 6.19 million shares in October as published by FINRA. Its up 8.4% from 5.71 million shares, reported previously. With 1.06 million shares average volume, it will take short sellers 6 days to cover their AMRX’s short positions. The short interest to Amneal Pharmaceuticals Inc Class A’s float is 11.85%.

The stock decreased 0.44% or $0.095 during the last trading session, reaching $21.395. About 27,706 shares traded. Amneal Pharmaceuticals, Inc. (NYSE:AMRX) has risen 4.29% since October 2, 2017 and is uptrending. It has underperformed by 11.33% the S&P500.

Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, makes, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. The company has market cap of $6.39 billion. It operates through Generic and Specialty Pharma divisions. It has a 18.32 P/E ratio. The company's generics portfolio includes approximately 200 product families marketed in various dosage forms, such as solid oral doses comprising tablets, capsules, and powders; liquids; sterile injectables; nasal sprays; inhalation and respiratory products; ophthalmics; films; transdermal patches; and topicals, as well as soft gel, complex molecule, and drug-device combinations.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>